Global sales of vaccines grew in 2009, according to healthcare market research publisher Kalorama Information, and researchers are forecasting sales to rise at a compound annual rate during the next five years.
Bristol-Myers Squibb’s ipilimumab has shown early promise for helping patients with advanced melanoma that has spread to the brain.
A new study showed that giving just one-fifth the usual dose of the polio vaccine may protect babies against the virus nearly as well as a full dose, as long as it is injected just beneath the skin, according to a recent study.
This new bill would allow plan sponsors to pay for off-label drug uses on a case-by-case basis and review the safety and efficacy of drugs.
A first-of-its-kind prostate cancer treatment that uses the body’s immune system to fight the disease has been approved by the U.S. Food and Drug Administration.
According to the Centers for Disease Control and Prevention, the rotavirus vaccine is now contraindicated for infants diagnosed with severe combined immunodeficiency.
Octapharma USA has initiated a voluntary withdrawal of all lots of Octagam (immune globulin intravenous [human] 5% liquid preparation) from the U.S. marketplace.
The Centers for Disease Control and Prevention has issued a comprehensive update on seasonal flu vaccination, which includes the new universal recommendation for everyone except infants younger than 6 months old.
A recent study shows measles-mumps-rubella-varicella (MMRV) vaccination is associated with an increased risk of fever and seizure in young children, above that already associated with measles-containing vaccines.
The U.S. Food and Drug Administration has launched two new websites relating to drug safety.
The U.S. government has begun to stockpile a new version of the smallpox vaccine that is designed to close a gap that left millions vulnerable to a bioterror attack.